Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
| Line 22: | Line 22: | ||
*[[Media:05 08 2020 QIBA CEUS BC Call Summary-FINAL.pdf|May 8, 2020]] | *[[Media:05 08 2020 QIBA CEUS BC Call Summary-FINAL.pdf|May 8, 2020]] | ||
*[[Media:03 13 2020 QIBA CEUS BC Call Summary-FINAL.pdf|March 13, 2020]] | *[[Media:03 13 2020 QIBA CEUS BC Call Summary-FINAL.pdf|March 13, 2020]] | ||
| − | + | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
'''''[[US CEUS Call Summary Archive]]''''' | '''''[[US CEUS Call Summary Archive]]''''' | ||
Revision as of 16:59, 22 June 2020
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: